Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Antitrust (1)
- Bioethics (1)
- Biopharmaceutical Companies (1)
- Biopharmaceutical Products (1)
- Business Ethics (1)
-
- CDTR (1)
- Commercial Speech (1)
- Common Law (1)
- Competitive Process (1)
- Corporate Duty To Rescue (1)
- FDA (1)
- First Amendment (1)
- Food and Drug Administration (1)
- Health Law (1)
- Image Advertisements (1)
- Intellectual Property (1)
- Juries (1)
- Jury Impartiality (1)
- Litigation (1)
- Litigation Hot Spots (1)
- Market Failure (1)
- Medications (1)
- Patent Rights (1)
- Patient Assistance Programs (1)
- Protected Speech (1)
- Rule of Reason (1)
- Seventh Amendment (1)
- Torts (1)
- Type of Effect (1)
- Voir Dire (1)
Articles 1 - 3 of 3
Full-Text Articles in Law
Influencing Juries In Litigation "Hot Spots", Megan M. La Belle
Influencing Juries In Litigation "Hot Spots", Megan M. La Belle
Indiana Law Journal
This Article considers how corporations are using image advertising in litigation "hot spots" as a means of influencing litigation outcomes. It describes how Samsung and other companies advertised in the Eastern District of Texas--a patent litigation "hot spot"--to curry favor with the people who live there, including by sponsoring an ice rink located directly outside the courthouse. To be sure, image advertisements are constitutionally protected speech and might even warrant the highest level of protection under the First Amendment when they are not purely commercial in nature. Still, the Article argues, courts should be able to prohibit such advertisements altogether, …
A Corporate Duty To Rescue: Biopharmaceutical Companies And Access To Medications, Rebecca E. Wolitz
A Corporate Duty To Rescue: Biopharmaceutical Companies And Access To Medications, Rebecca E. Wolitz
Indiana Law Journal
Controversies regarding the pricing of biopharmaceutical products are pervasive. Patients must choose between treatment and rent, prescriptions go unfilled, and health systems are forced to restrict access to life-saving medications— all because of cost. Though there is often consensus that these issues are problematic, there is disagreement as to what are appropriate solutions and who has responsibility to bring about those solutions. Most efforts to address biopharmaceutical pricing concerns focus on governmental regulation. This Article has a different focus. It provides a legal and normative analysis of a form of corporate self-regulation that could help address access and pricing concerns—a …
Procompetitive Justifications In Antitrust Law, John M. Newman
Procompetitive Justifications In Antitrust Law, John M. Newman
Indiana Law Journal
The Rule of Reason, which has come to dominate modern antitrust law, allows defendants the opportunity to justify their conduct by demonstrating procompetitive effects. Seizing the opportunity, defendants have begun offering increasingly numerous and creative explanations for their behavior.
But which of these myriad justifications are valid? To leading jurists and scholars, this has remained an “open question,” even an “absolute mystery.” Examination of the relevant case law reveals multiple competing approaches and seemingly irreconcilable opinions. The ongoing lack of clarity in this area is inexcusable: procompetitive-justification analysis is vital to a properly functioning antitrust enterprise.
This Article provides answers …